MD862G2 - Remedy for dislipidemy and atherosclerosis treatment - Google Patents
Remedy for dislipidemy and atherosclerosis treatmentInfo
- Publication number
- MD862G2 MD862G2 MD97-0168A MD970168A MD862G2 MD 862 G2 MD862 G2 MD 862G2 MD 970168 A MD970168 A MD 970168A MD 862 G2 MD862 G2 MD 862G2
- Authority
- MD
- Moldova
- Prior art keywords
- dislipidemy
- remedy
- atherosclerosis treatment
- pectine
- increasing
- Prior art date
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 abstract 2
- 230000000871 hypocholesterolemic effect Effects 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- -1 calcium cations Chemical class 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000006266 etherification reaction Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the medicine and particularly, to the cardiology.Summary of the invention consists in the fact that the remedy for dislipidemy and atherosclerosis treatment on polysacharids base includes pectine having an etherification level higher than 70%, with hypocholesterolemic effect, which contains calcium cations in the quantity of 300-500 mg-equiv./kg, particularly apple pectine.The technical result consists in increasing the hypocholesterolemic properties with gtriglycerides decreasing and C-HDL level increasing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0168A MD862G2 (en) | 1997-06-23 | 1997-06-23 | Remedy for dislipidemy and atherosclerosis treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0168A MD862G2 (en) | 1997-06-23 | 1997-06-23 | Remedy for dislipidemy and atherosclerosis treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD862F1 MD862F1 (en) | 1997-10-31 |
| MD862G2 true MD862G2 (en) | 1998-07-31 |
Family
ID=19739022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD97-0168A MD862G2 (en) | 1997-06-23 | 1997-06-23 | Remedy for dislipidemy and atherosclerosis treatment |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD862G2 (en) |
-
1997
- 1997-06-23 MD MD97-0168A patent/MD862G2/en not_active IP Right Cessation
Non-Patent Citations (2)
| Title |
|---|
| A.S. Truswell. " Dietary Fibre and Plasma Lipids: Potential for Prevention and Treatment of Hyperlipidaemias.Dietary Fibre-A component of food.1993.p.295-348. * |
| Cs. gastroenterologie, V.37,N1, E. Ginter, R. Kohn, A. Malovicova et al. " Zavislost. Hipolipemickeno ucinki pectinov na ich chemickom Zlozeni", p.37-46. * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD862F1 (en) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
| MX9700223A (en) | Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension. | |
| BG102726A (en) | Combined therapy for osteoporosis | |
| BG105556A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
| GR970300016T1 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
| IL214607A0 (en) | 2,4-pyrimidinedinediamine compounds and their use in the manufacture of medicaments for the treatment of autoimmune disases | |
| BG104943A (en) | Biodegradable sustained-release alginate gels | |
| ZA200110504B (en) | Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria. | |
| ES2191174T3 (en) | (-) MAGNESIUM HYDROXICITRATE, PREPARATION PROCEDURE, APPLICATIONS AND MAIN PHARMACEUTICAL COMPOSITIONS CONTAINING IT. | |
| MX9704030A (en) | 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. | |
| AU3259099A (en) | Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method | |
| MXPA04002565A (en) | Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation. | |
| PL340561A1 (en) | Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders | |
| EP0606903A3 (en) | Connector. | |
| ZA948B (en) | Endothelin converting enzyme inhibitors | |
| SI0951909T1 (en) | Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof | |
| EP0940316A3 (en) | Drawer tower | |
| BG105256A (en) | Muscarinic agonists and antagonists | |
| AU4830097A (en) | Use of an extract of Cimicifuga | |
| EP0615728A3 (en) | Orthopaedic reconstruction plate. | |
| EP1275379A3 (en) | Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| BR9812368A (en) | 2-aminotetralins, process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and / or autoimmune pathologies | |
| AU6849198A (en) | Neurotrypsin | |
| BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
| NZ525536A (en) | Treatment of arthritis and other similar conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Granted patent for invention | ||
| IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20170623 |
|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |